January 20, 2018 4:11 PM ET

Health Care Technology

Company Overview of Definiens AG

Company Overview

Definiens AG provides biomedical image analysis and data mining software solutions for life sciences, tissue diagnostics, and clinical digital pathology markets. It offers Definiens Tissue Studio, a solution for biomarker and morphological profiling in research and drug discovery on tissue samples, as well as detects regions of interest and distinguishes cell types and cell subtypes within target regions across various tissue slides; and Definiens Developer XD, a solution for scientists and image analysis experts to create and validate automated solutions for a range of biomedical image analysis problems. The company also provides Definiens Image Miner, a solution that integrates data mining...

Bernhard-Wicki-Straße 5

Munich,  80339

Germany

Founded in 1994

Phone:

49 89 2311800

Fax:

49 89 23118090

Key Executives for Definiens AG

Chief Executive Officer
Founder, Chief Technology Officer and Director
Chief Financial Officer
Chief Operating Officer
Compensation as of Fiscal Year 2017.

Definiens AG Key Developments

Definiens Announces Executive Changes

Definiens announced the strengthening of its leadership team. To support the company’s strategic expansion Definiens appointed Dr. Heinz Oehl as VP of Global Marketing & Corporate Business Development. In addition, Michael Rasche, formerly Global Head of Sales and Business Development, has been promoted to Chief Commercial Officer (CCO). Dr. Heinz Oehl is an MD with more than 15 years of experience in the healthcare and life science industries. With Michael Rasche’s leadership Definiens has experienced significant business growth in oncology and immuno-oncology partnerships with the most relevant I/O Pharma and Biotech companies.

NeoGenomics, Inc. and Definiens Enter into Agreement to Develop Novel Assays for Clinical Trials and Clinical Testing

NeoGenomics, Inc. and Definiens announced that they have expanded their alliance to develop and automate the analysis of new biomarker assays for clinical trials and routine clinical testing. Under the agreement, Definiens will provide automated quantitative biomarker solutions to support NeoGenomics' immunohistochemistry services for both its Pharma Services customers and Clinical clients, helping to improve pathology interpretation, standardize the readout (analysis/scoring), and identify the signature for optimal biomarker cut point threshold. NeoGenomics excels in providing custom developed Immunohistochemistry (IHC) assays to be used in clinical trials, companion diagnostics and clinical testing. Automated IHC workflows, quantification, and interpretation tools remove variability of pathology scoring criteria and will allow researchers and pathologists a higher level of analytical consistency to standardize biomarker analysis for global clinical trials and clinical testing.

Definiens Expands Boston-Based Office in Response to Growth in U.S. Market

Definiens announced that it is expanding its presence in the U.S. to meet growing customer needs. The company opened its Boston office last year, and since then has experienced significant growth in providing tissue-based services to pharmaceutical companies, academic medical centers, comprehensive cancer centers and biotech companies in North America, prompting further expansion in the market. The office, based just outside Boston in Cambridge, MA, will become the company’s new U.S. headquarters. The company will continue to focus on enhancing its offerings for customers, and as part of that will be recruiting additional technical engineering employees as well as commercial leaders for the Boston office.

Similar Private Companies By Industry

Company Name Region
ADDPLAN GmbH Europe
ADVANOVA GmbH Europe
Aescuvest GmbH Europe
Aiomed GmbH Europe
AnagnosTec Gmbh Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
NYC2012, Inc. United States
John F. Kennedy Center For The Performing Arts United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Definiens AG, please visit www.definiens.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.